About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

The PediQUEST Response Intervention Study | Clinical Trials | Clareo Health

COMPLETEDNA

The PediQUEST Response Intervention Study

A Multisite, Parallel, RCT Comparing the Effectiveness of an Early Palliative Care Intervention, the PediQUEST Response to Pediatric Oncology Symptom Experience , Versus Usual Cancer Care in Children and Adolescents With Advanced Cancer

NCT03408314•Joanne Wolfe, MD, MPH

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Advanced Cancer

Interventions

PediQUEST Response

Usual Cancer Care

Locations

6

United States

Locations (6)

Ann & Robert H. Lurie Children's Hospital of Chicago

Chicago, Illinois, United States

Boston Children's Hospital

Boston, Massachusetts, United States

Dana Farber Cancer Institute

Boston, Massachusetts, United States

The Children's Hospital of Philadelphia

Philadelphia, Pennsylvania, United States

Texas Children's Hospital

Houston, Texas, United States

Seattle Children's Research Institute

Seattle, Washington, United States

Key Dates

Start Date

March 1, 2018

Primary Completion Date

September 14, 2022

Completion Date

September 14, 2022

Last Updated

November 29, 2024

Related Studies

RECRUITINGPhase 1/2

Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer

NCT05735080

Breast CancerBreast Cancer Metastatic+7 more

RECRUITINGPhase 1/2

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

NCT04657068

Advanced CancerMetastatic Cancer+7 more

RECRUITINGPhase 1

Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors

NCT04900818

Solid TumorAdvanced Cancer+6 more

RECRUITINGPhase 1/2

A Study of Repotrectinib in Combination With Chemotherapy in Children and Young Adults With Solid Tumor Cancer

NCT05004116

Advanced CancerMetastatic Solid Tumor

Development of an Educational Patient Decision Aid (Treatments in Advanced Cancer - Decision Aid, TA-DA) to Promote Shared Decision Making for Third-line or Beyond Palliative Systemic Therapy

NCT07009886

Advanced Cancer

RECRUITINGPhase 1

A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors

NCT06440005

CancerAdvanced Cancer+9 more

View all related studies

Sponsors

Lead Sponsor

Joanne Wolfe, MD, MPH

Collaborators

Children's Hospital of Philadelphia
Seattle Children's Hospital
St. Jude Children's Research Hospital
Children's Hospitals and Clinics of Minnesota
Nationwide Children's Hospital
University of Alabama at Birmingham
Deakin University
Boston Children's Hospital
Ann & Robert H Lurie Children's Hospital of Chicago
Baylor College of Medicine
Dana-Farber Cancer Institute
National Institute of Nursing Research (NINR)

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 29, 2024Data synced to Clareo: April 27, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions